Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5436 participants.
Also called NCT06523959
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 5,436 participants
- Sponsor
- Registry
-
NCT06523959 -
2023-508147-43-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Finland
- Registry status
- Recruiting
Technical summary
Registry record NCT06523959. Randomized; no masking; primary purpose treatment. Start 2024-06-06 (actual); primary completion 2028-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial
- Acronym
- ARTS
- Condition
- Venous Thromboembolism
- Condition
- Bleeding
- Intervention (Drug)
- Apixaban 2.5 MG
- Lead sponsor
- Clinical Urology and Epidemiology Working Group
- Collaborator
- Helsinki University Central Hospital
- Collaborator
- University of Helsinki
- Collaborator
- University College, London
- Collaborator
- Population Health Research Institute
- Collaborator
- Tabriz University of Medical Sciences
- Collaborator
- Tampere University Hospital
- Collaborator
- Turku University Hospital
- Collaborator
- Oulu University Hospital
- Collaborator
- North Karelia Central Hospital
- Collaborator
- Albany Medical College
- Collaborator
- PaijatHame Central Hospital
Record details
- Record id
cardio:ct-nct06523959- Content hash
837eb9d7435b50e78b40c978ffdabb5c8b5befdf44960054096e020c9f873c33